The cost-effectiveness of early resuscitation of sepsis in Australia - an economic evaluation alongside the ARISE-RCT

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/579709

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Critical care treatment is expensive and consumes a significant portion of hospital resources. This study will collect cost, survival and quality of life data on a group of sepsis patients enrolled in a trial of strict protocolised treatment versus standard care (the ARISE study). This information will be used to determine how much it costs for each additional survivor with protocolised treatment, and how much it costs for each quality adjusted life year gained with protocolised treatment.

Funded Activity Details

Start Date: 01-01-2009

End Date: 01-01-2013

Funding Scheme: NHMRC Postgraduate Scholarships

Funding Amount: $115,971.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Inorganic green chemistry

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Cost effectiveness | Critical care medicine | Economic evaluation | Intensive care | Sepsis

Related Links